6XG-26973-40371
3 vaccinations
6 coded responses
15 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 975 / OR
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Dose 1 — Pfizer-BioNTech
-
2021-01-19
Registered in v-safe
-
2021-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-01-23
Survey response — day 7, dose 1MedDRA: Pre-existing disease — Feeling: Good · Muscle or body aches, Fatigue or tirednessFree text: Im on Afinitor for metastatic breast cancer. Im usually achy and tiredMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
-
2021-02-06
Dose 2 — Pfizer-BioNTech
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-05-08
-
2021-08-07
Survey response — 6 months, dose 2MedDRA: Asthenia, Brain fog, Rash, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Rash on elbow. Lack of energy. Foggy brain · Healthcare visit (other): Labs and CTMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-07
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-19
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Survey response — day 35, dose 3MedDRA: Fatigue — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-09-30
-
2021-11-18
Survey response — 3 months, dose 3MedDRA: Asthenia, Exercise tolerance decreased, Impaired work ability, Lethargy — Feeling: Fair · Be unable to work or attend schoolFree text: Contó used to become very lethargic to the point that I couldn't work. Increased antidepressant and took med vacation from Afinitor for a month to try to regain strength and endurance.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-01
-
2022-02-17
Survey response — 6 months, dose 3MedDRA: Pain in extremity, Paraesthesia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tingling pain in my hands and feet.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-17
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-21
Call successfulDoes not wish to fill out VAERS report
-
2022-08-19
Survey response — 12 months, dose 3MedDRA: Bone cancer metastatic, Brain cancer metastatic, Metastases to spine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cancer metastasis to my right femur, skull, shoulders, spine and now brain.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-06 | Pfizer-BioNTech | |
| 3 | 2021-08-19 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
1 wait over 3 months for a first call
Free text
Release 2 — day 7, dose 1
Systemic reaction (other): Im on Afinitor for metastatic breast cancer. Im usually achy and tired
Release 9 — 6 months, dose 2
Symptoms: Rash on elbow. Lack of energy. Foggy brain
Healthcare visit (other): Labs and CT
Release 9 — day 35, dose 3
Symptoms: Fatigue
Release 10 — 3 months, dose 3
Symptoms: Contó used to become very lethargic to the point that I couldn't work. Increased antidepressant and took med vacation from Afinitor for a month to try to regain strength and endurance.
Release 11 — 6 months, dose 3
Symptoms: Tingling pain in my hands and feet.
Release 12 — 12 months, dose 3
Symptoms: Cancer metastasis to my right femur, skull, shoulders, spine and now brain.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | · | ✓ |
| SD | Asthenia | ✓ | · | ✓ |
| SD | Bone cancer metastatic | · | · | ✓ |
| SD | Brain cancer metastatic | · | · | ✓ |
| SD | Brain fog | ✓ | · | ✓ |
| SD | Exercise tolerance decreased | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Metastases to spine | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Rash | ✓ | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release